PATH defends itself against Indian criticisms of HPV project – FierceVaccines

PATH defends itself against Indian criticisms of HPV project
FierceVaccines
The once hotly tipped Indian clinical trial sector has slowed in recent years as criticisms of overseas organizations have intensified and factions have fought over how best to regulate studies. Nonprofit PATH is the latest to come under attack. PATH

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *